https://www.xrnax.com/home daily 1.0 2020-03-03 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520188861209-VEVZ69IQ77MERSZBP0OT/F4_banner.png home https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520244199788-R7AH7L41VUFGSYM87JU2/xrnax_banner_g60.png home https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520245149143-13LQ0H0V6917ILH6Q8UR/F4_banner.png home https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520245518998-EEFKOFV64CRCDJIR1WFE/F1_banner.png home https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520407293111-I5PSIRZJX50IZA0WUOE9/F3_banner.png home https://www.xrnax.com/faq daily 0.75 2019-01-02 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520244236120-XL14GOXDC6751BC4PO44/xrnax_banner_g60.png FAQ https://www.xrnax.com/faq/2019/1/2/interphase-4-what-about-formaldehyde monthly 0.5 2019-01-02 https://www.xrnax.com/faq/2019/1/2/interphase-3-why-uv-crosslinking monthly 0.5 2019-01-09 https://www.xrnax.com/faq/2018/12/30/interphase-2-non-quantitative-peptides-are-a-feature-not-a-bug monthly 0.5 2018-12-31 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1546168365155-LXCUK1WXDYGXNK14YSOC/Figure+S1F.png FAQ - Interphase 2: Non-quantitative peptides are a feature, not a bug. Figure 1F of the Cell manuscript. Same amounts of UV-crosslinked and non-crosslinked cells with different SILAC labels were combined and subjected to XRNAX or XRNAX and silica enrichment. https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1546167845759-BVWH8O3QW6UBH7V9WHYI/Figure+S1G.png FAQ - Interphase 2: Non-quantitative peptides are a feature, not a bug. Figure S11G of the Cell manuscript. A dilution series of UV-crosslinked and non-crosslinked MCF7 cells is prepared and subjected to XRNAX and silica enrichment. https://www.xrnax.com/faq/2018/12/30/interphase-1-why-have-a-background-control-why-silica-enrichment-after-xrnax monthly 0.5 2018-12-30 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1546167452872-JNOLQU8NLFAMHRDLOAVS/Figure+S1D.png FAQ - Interphase 1: Why have a background control? Why silica enrichment after XRNAX? Figure S1D of the Cell manuscript. Same amounts of UV-crosslinked and non-crosslinked cells with different SILAC labels were combined and subjected to XRNAX or XRNAX and silica enrichment. How much of a peptide comes from the UV-crosslinked channel is calculated with the formula Xlinked = (Xlink/control) / (Xlink/control +1). https://www.xrnax.com/faq/2018/12/30/conceptions-and-misconceptions-about-the-trizol-interphase monthly 0.5 2018-12-30 https://www.xrnax.com/faq/2018/6/21/rna-integrity-and-quality-control-of-xrnax-extracts monthly 0.5 2018-06-21 https://www.xrnax.com/faq/2018/3/5/about-faq monthly 0.5 2018-03-05 https://www.xrnax.com/theprotocol daily 0.75 2018-06-04 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520246938280-54P6XLLUFKNS8CEJYCD9/0.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248013107-TDOLAVIKZLTZH57NIFBM/7.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248196896-Z20ASTTG5SPQKBQIVI3D/13.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248625339-B98PLYH8JZV8CJURPIXP/13_14.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248042411-1XEX7LJL45KAR131MQRY/10.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520247733207-QNR46WR3DSZP2CDBJKP2/1.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248001088-41VEG6B6JJEONB4VPLLG/5.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248035666-6RT9E5RQW97KXN3CW7U3/9.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248067944-ZFBDLPSQ3HQMA7Z10FUR/12.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520247985090-7JVHCH1DPBIJGE6PN9YH/3.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248010347-4V44S36NWK8WNRHFE9IE/6.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520247972620-EYX8EEDHF3C1K0D9Y6D4/2.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1528127677049-4RZNK9CPXAQ9PP6ARP7H/QC.jpg the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520250592036-XEESM6EZGKOAKLNQUSCW/11.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520247995275-6HZKTMF1W1MZLYXFRXAB/4.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248022534-JF8JH9BX1UNHR4ITQN64/8.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248254210-JGC8KECIDGDEXB4JYEK1/10b.png the protocol https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520248392518-OQ0KJX2OSOCXKHA97MLJ/11b.png the protocol https://www.xrnax.com/contact daily 0.75 2019-01-31 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520244300835-YGDJOCXOFMK0S9J44M2Y/xrnax_banner_g60.png contact https://www.xrnax.com/applications daily 0.75 2018-09-28 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520260120273-FYE1247VQTQ2QLEDV6Y1/applications_XRNAXpeptides.png Applications https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1538147510374-SQFURAXL39VF8RUDXWQ9/XRNAX_website_applications_F5.png Applications https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520255810943-DKTWR7GTXRF5NG4OA091/applications_RBPome.png Applications https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520261350545-7L61D22BR9GUUAZKDS1N/applications_XRNAXclip.png Applications https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520257596167-XUWT2GVLV65798U4N590/applications_diffRBPome.png Applications https://www.xrnax.com/applications-1 daily 0.75 2018-09-28 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520257426331-PXF6TY19W3OUIMFWW7IW/applications_RBPome_fractions.png Exploration of RNA-Binding Proteomes https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520255810943-DKTWR7GTXRF5NG4OA091/applications_RBPome.png Exploration of RNA-Binding Proteomes https://www.xrnax.com/applications-2 daily 0.75 2019-02-13 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520257596167-XUWT2GVLV65798U4N590/applications_diffRBPome.png Quantification of Differential RNA-Binding https://www.xrnax.com/applications-3 daily 0.75 2018-09-28 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520260120273-FYE1247VQTQ2QLEDV6Y1/applications_XRNAXpeptides.png Purification of Nucleotide-Crosslinked Peptides https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520260343099-Z92QJK41P2EODSAX4Z4F/applications_XRNAXpeptides_fractions.png Purification of Nucleotide-Crosslinked Peptides https://www.xrnax.com/applications-4 daily 0.75 2018-09-28 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1520261350545-7L61D22BR9GUUAZKDS1N/applications_XRNAXclip.png Crosslinking and Immunoprecipitation Followed by Sequencing https://www.xrnax.com/applications-5 daily 0.75 2018-09-28 https://images.squarespace-cdn.com/content/v1/5a9833981aef1d6befd64466/1538171784042-YN49R7ACRMJBHD0AW2QV/XRNAX_website_applications_F5.png Crosslinking and Immunoprecipitation Followed by MS